Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 2/20 | 0.70 |
| ▸ | ELANE | P08246 | 2/20 | 0.64 |
| ▸ | F2 | P00734 | 1/20 | 0.64 |
| ▸ | PLG | P00747 | 1/20 | 0.64 |
| ▸ | CTSG | P08311 | 1/20 | 0.64 |
| ▸ | CMA1 | P23946 | 1/20 | 0.64 |
| ▸ | CTRC | Q99895 | 1/20 | 0.64 |
| ▸ | GSK3A | P49840 | 4/20 | 0.60 |
| ▸ | GSK3B | P49841 | 4/20 | 0.60 |
| ▸ | MGLL | Q99685 | 1/20 | 0.59 |
| ▸ | CA12 | O43570 | 1/20 | 0.56 |
| ▸ | CA1 | P00915 | 1/20 | 0.56 |
| ▸ | CA2 | P00918 | 1/20 | 0.56 |
| ▸ | CA9 | Q16790 | 1/20 | 0.56 |
| ▸ | MEN1 | O00255 | 5/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.53 |
| ▸ | MAPT | P10636 | 2/20 | 0.53 |
| ▸ | APAF1 | O14727 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bicarbonate SCHEMBL25171118 | 0.94 | POLB (0.64) | POLBELANEF2PLGCTSG | |
| SCHEMBL40679 | 0.91 | POLB (0.61) | POLBELANEF2PLGCTSG | |
| SCHEMBL5769842 | 0.88 | MGLL (0.65) | POLBELANEF2PLGCTSG | |
| SCHEMBL31114554 | 0.86 | POLB (0.60) | POLBELANEF2PLGCTSG | |
| SCHEMBL10688767 | 0.83 | POLB (1.00) | POLBMEN1KMT2AL3MBTL1ALDH1A1 | |
| SCHEMBL29880432 | 0.83 | POLB (1.00) | POLBMEN1KMT2AL3MBTL1ALDH1A1 | |
| SCHEMBL17725335 | 0.83 | POLB (0.57) | POLBELANEF2PLGCTSG | |
| SCHEMBL17712991 | 0.83 | POLB (0.57) | POLBELANEF2PLGCTSG | |
| SCHEMBL10559302 | 0.81 | GSK3A (0.70) | POLBELANEF2PLGCTSG | |
| SCHEMBL11620172 | 0.81 | ELANE (0.57) | POLBELANEF2PLGCTSG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 198 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025121320-A1 | PROPHYLACTIC OR THERAPEUTIC AGENT FOR POLYCYSTIC KIDNEY DISEASE | 国立大学法人山口大学 | 2025-06-12 | — | — | WO | claimed |
| CN-119977886-A | Pentazocine gluconate benzoate and preparation method and application thereof | 安徽益普克医药科技发展有限公司 | 2025-05-13 | — | — | CN | claimed |
| CN-118851946-A | Method for preparing long fatty chain diacid derivative and application thereof | 广东东阳光药业股份有限公司 | 2024-10-29 | — | — | CN | claimed |
| CN-113264866-B | Non-fluorescent organic small molecular compound, preparation method of pentamethyl cyanine dye and application of pentamethyl cyanine dye | 南京大学 | 2023-04-07 | — | — | CN | claimed |
| CN-113264866-A | Non-fluorescent organic small molecular compound, preparation method of pentamethyl cyanine dye and application of pentamethyl cyanine dye | 南京大学 | 2021-08-17 | — | — | CN | claimed |
| EP-2859069-B1 | METHOD AND APPARATUS FOR TREATING PETROLEUM EQUIPMENT | FERRARA MARCELLO (IT) | 2020-10-14 | — | — | EP | claimed |
| US-9328300-B2 | Method, apparatus and chemical products for treating petroleum equipment | FERRARA MARCELLO (IT) | 2016-05-03 | — | — | US | claimed |
| EP-2859069-A1 | METHOD AND APPARATUS FOR TREATING PETROLEUM EQUIPMENT | Ferrara, Marcello (IT) | 2015-04-15 | — | — | EP | claimed |
| WO-2013156228-A1 | METHOD AND APPARATUS FOR TREATING PETROLEUM EQUIPMENT | FERRARA MARCELLO (IT) | 2013-10-24 | — | — | WO | claimed |
| US-20130270157-A1 | METHOD, APPARATUS AND CHEMICAL PRODUCTS FOR TREATING PETROLEUM EQUIPMENT | FERRARA MARCELLO (IT) | 2013-10-17 | — | — | US | claimed |
| WO-2009149054-A1 | SMALL MOLECULE INHIBITORS FOR THE TREATMENT OR PREVENTION OF DENGUE VIRUS INFECTION | SIGA TECHNOLOGIES, INC. (US) | 2009-12-10 | — | — | WO | claimed |
| US-20040127707-A1 | PDE4/7 inhibitors useful in treatment of airway disorders, autoimmune system disorders, skin disorders, arthritis, nerve system disorders | ALTANA PHARMA AG (DE) | 2004-07-01 | — | — | US | claimed |
| EP-1385848-A2 | PHTALAZINONES DERIVATIVES USEFUL AS PDE4/7 INHIBITORS | ALTANA Pharma AG (DE) | 2004-02-04 | — | — | EP | claimed |
| EP-0971901-B1 | PHTHALAZINONES | ALTANA PHARMA AG (DE) | 2003-02-26 | — | — | EP | claimed |
| WO-2002085906-A2 | PHTHALAZINONES DERIVATIVES USEFUL AS PDE4/7 INHIBITORS | ALTANA PHARMA AG (DE) | 2002-10-31 | — | — | WO | claimed |
| US-6103718-A | Phthalazinones | BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) | 2000-08-15 | — | — | US | claimed |
| EP-0971901-A1 | PHTHALAZINONES | Byk Gulden Lomberg Chemische Fabrik GmbH (DE) | 2000-01-19 | — | — | EP | claimed |
| WO-1998031674-A1 | PHTHALAZINONES | BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) | 1998-07-23 | — | — | WO | claimed |
| WO-1995020637-A2 | HYDROCARBON OIL-AQUEOUS FUEL AND ADDITIVE COMPOSITIONS | MEG S.N.C. DI SCOPELLITI SOFIA & C. (IT) | 1995-08-03 | — | — | WO | claimed |
| EP-0310854-A1 | Process for the manufacture of 3-amino-1-benzyl-pyrrolidines | BAYER AG (DE) | 1989-04-12 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040127707-A1 | PDE4/7 inhibitors useful in treatment of airway disorders, autoimmune system disorders, skin disorders, arthritis, nerve system disorders | PDE4A, PDE4B, PDE7B | POLB 972/4885ELANE 1636/4885F2 4668/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.